Regulatory Science for Innovative Medicines
National Institute of Health Sciences

What's new

  • New HP of our division is created
  • Nov. 25th 2015 The new division of Molecular Target and Gene Therapy Products was established

About us

Recent progress in life sciences, especially rapid advances in genome research, regenerative medicine and biotechnology, provide new approaches to innovative therapeutics such as cellular and gene therapy products, and gene diagnostics.

In the Division of Cellular and Gene Therapy Products (CGTP), which was newly established in April, 2002, we are engaged in the study for evaluation of the quality, safety and efficacy of cellular and gene therapy products, and diagnostic drugs.
Biochemical and molecular biological studies associated with these areas are also conducted in our division.